BKQ-25681-01531 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-31
Dose 1 — Pfizer-BioNTech
2021-04-01
Registered in v-safe
2021-04-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-02
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-03
Survey response — days 1–6 daily, dose 1
MedDRA: Anxiety, Panic attack — Feeling: Fair · Be unable to do your normal daily activities

Free text: Panic attack, anxiety

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Rash, not including the immediate area around the injection site

Adult check-in
2021-04-08
Survey response — day 7, dose 1
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-14
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-22
Dose 2 — Pfizer-BioNTech
2021-04-22
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-05-01
Health check-in — day 7, dose 2
Feeling: Fair · Nausea · Be unable to do your normal daily activities

Adult check-in
2021-05-07
Survey response — day 14, dose 2
MedDRA: Abdominal discomfort, Decreased appetite — Feeling: Fair · Be unable to do your normal daily activities

Free text: Lack of appetite, stomach issues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-13
Survey response — day 21, dose 2
MedDRA: Decreased appetite, Weight decreased — Feeling: Fair · Be unable to do your normal daily activities

Free text: Lack of appetite, weight loss, stomach issues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-04
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-22
Survey response — 3 months, dose 2
MedDRA: Menstruation irregular — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Irregular menstrual cycle

MedDRA releases: 2024-11 · check-in free text available
2021-07-22
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-28
Call 1 — Left Voicemail
2021-10-23
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-14
Dose 3 — Pfizer-BioNTech
2022-04-22
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-06-14
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-12-14
Survey response — 12 months, dose 3
MedDRA: Biochemical pregnancy, Failed in vitro fertilisation, Herpes zoster — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Shingles - 6/22 Chemical pregnancy - 4/22 Failed frozen embryo transfer - 9/22

MedDRA releases: 2024-11 · check-in free text available
2022-12-14
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-15
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-12-15
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-31	Pfizer-BioNTech
2	2021-04-22	Pfizer-BioNTech
3	2021-12-14	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-07-22	Successful 2022-12-15	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-12-14	Successful 2022-12-15	Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-03

Systemic reaction (other): Panic attack, anxiety

Release 7 — day 7, dose 1

2021-04-08

Systemic reaction (other): Dizziness

Release 8 — day 14, dose 2

2021-05-07

Symptoms: Lack of appetite, stomach issues

Release 8 — day 21, dose 2

2021-05-13

Symptoms: Lack of appetite, weight loss, stomach issues

Release 9 — 3 months, dose 2

2021-07-22

Symptoms: Irregular menstrual cycle

Release 12 — 12 months, dose 3

2022-12-14

Symptoms: Shingles - 6/22 Chemical pregnancy - 4/22 Failed frozen embryo transfer - 9/22

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal discomfort	✓	✓	✓
SD	Biochemical pregnancy	·	·	✓
SD	Decreased appetite	✓	✓	✓
SD	Failed in vitro fertilisation	·	·	✓
SD	Herpes zoster	·	·	✓
SD	Menstruation irregular	·	·	✓
SD	Weight decreased	✓	✓	✓
SRO	Anxiety	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Panic attack	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release